In addition to establish ing an Exposure Limit (in workplace air), the review provided “good practice” guidance on the most up-to-date procedures for biological monitoring of certain blood or urine metabo lites associated with the substance so that we can know that the substance either does not exist or is at a safe level that would not cause any adverse effect.